InvestorsHub Logo
Followers 32
Posts 3544
Boards Moderated 0
Alias Born 07/02/2004

Re: konshe post# 82

Tuesday, 08/27/2013 5:31:11 PM

Tuesday, August 27, 2013 5:31:11 PM

Post# of 1397
Yup, hard to argue that. Unlike other P&Ds, they actually have a product that sells and has a niche in the kidney care market.

At .07 a share, the dilution required to raise any reaonable amount of money would kill the share structure.....not to mention every time it pops, the selling gets ferocious and relentless.